FastMarket.news

Cathay General Bancorp Declares $0.34 Dividend Per Share

Published 5 hours agoCATY
Cathay General Bancorp Declares $0.34 Dividend Per Share

Cathay General Bancorp, trading under the symbol CATY on Nasdaq, has announced a quarterly cash dividend of $0.34 per common share. The company specified that the record date for this dividend is May 30, 2025, with payment scheduled for June 10, 2025. This announcement underscores Cathay General Bancorp's dedication to providing steady shareholder returns.


As the holding company for Cathay Bank, Cathay General Bancorp operates more than 60 branches across the U.S. and internationally. According to Business Wire, this stable dividend payout aligns with their financial strategy aimed at consistent shareholder benefits.


Currently, Cathay General Bancorp's stock price stands at $44.43, marking a marginal change of $0.07 (0.00%) from the previous close. The stock saw an intraday high of $44.765 and low of $44.16, with an intraday volume of 303,576 on the latest trading session as of Friday, May 16.

Share this article

Recent Articles

Novo Nordisk CEO Resigns Amid Sharp Share Price Drop

Novo Nordisk CEO Resigns Amid Sharp Share Price Drop

11 minutes agoNVO

Novo Nordisk is set for a leadership change as CEO Lars Fruergaard Jørgensen steps down amidst growing competitive pressures and a notable decline in the company's share value. Jørgensen will remain in the role during the transition period while the company seeks his successor, as reported by Reuters. The announcement follows a concerning 25% drop in Novo Nordisk's shares in March 2025, marking the company's largest monthly decline since July 2002. This downturn is largely attributed to intensified competition in the obesity drug market, especially from Eli Lilly's Zepbound, which has shown more impressive results in clinical trials. As part of its strategic response, Novo Nordisk is focusing on expanding its product lineup and boosting production capacity to cater to rising demand. Additionally, the company faces potential regulatory challenges, such as U.S. drug price negotiations, which could impact future revenue streams, particularly for widely used medications like Ozempic and Wegovy.

Goldman Sachs Eyes Revival in IPO Market Activity

Goldman Sachs Eyes Revival in IPO Market Activity

41 minutes agoGS

Goldman Sachs is seeing signs of renewed vigor in the initial public offering (IPO) market, a welcome shift following a period marked by slow activity. CEO David Solomon expressed optimism about a rebound, suggesting that the market, which had been largely inactive, is set for a resurgence, as reported by NBC Chicago. Contributing to this positive outlook is Goldman Sachs' IPO Issuance Barometer, which climbed to 93, indicating a more conducive environment for public offerings. Additionally, investor sentiment appears to be on the rise, with over half of those surveyed expressing more confidence than last year, many of whom anticipate a 'soft landing,' potentially spurring increased interest in IPOs, according to data from Goldman Sachs. Anticipation is building around several high-profile IPOs, notably those of Arm and Instacart, which are expected to invigorate market activity and potentially encourage other companies to follow suit. Goldman Sachs is poised to take advantage of this trend by leveraging its expertise in equity capital markets to facilitate these listings, aiming to bolster its market position as the IPO landscape revitalizes.

Oppenheimer Sees Potential in Coinbase Amid Stock Slide

Oppenheimer Sees Potential in Coinbase Amid Stock Slide

56 minutes agoCOIN

Oppenheimer analysts have expressed optimism about Coinbase Global Inc., suggesting that the recent downturn in the company's stock may be overdone. Despite adjusting their price target from $358 to $334, the firm maintains an 'Outperform' rating on Coinbase, viewing the current stock price as a potential buying opportunity. This perspective comes in light of a significant sell-off since late December that has seen the stock’s current price rest at $244.44 as per the latest trading data. Supporting this optimism, Oppenheimer highlights several positive market indicators. The firm expects a strong performance in the fourth quarter of 2024 for Coinbase and sees the potential inclusion of the company in the S&P 500 index by 2025. Additionally, the analysts recognize a favorable regulatory environment due to a pro-crypto administration and Congress, which could enhance Coinbase’s prospects. Further, the growth outlook includes increased adoption of blockchain technology for payments and tokenization, and an influx of new capital as traditional financial companies engage more with the crypto space. Reuters reports that Oppenheimer anticipates these factors could lead to a significant expansion for Coinbase, marking the recent price drop as an attractive entry point for investors.

Lockheed Martin Strengthens European Defense Ties Amid EU Push for Local Procurement

Lockheed Martin Strengthens European Defense Ties Amid EU Push for Local Procurement

1 hours agoLMT

Lockheed Martin is stepping up its partnerships in Europe as the European Union pushes for increased local defense procurement. In a significant move, Lockheed Martin and Rheinmetall have extended their cooperation to establish a new 'center of excellence' focused on the production of rockets and missiles. This facility is set to operate within Germany and across other European regions, aiming to enhance local manufacturing capacities, as reported by Reuters. In addition to manufacturing collaboration, Lockheed Martin has secured deals with European countries like Poland and the Netherlands for the purchase of JASSM-ER missiles through the U.S. Government’s Foreign Military Sales (FMS) program. This integration underscores the continuing use of U.S. defense technology within European military arsenals. Furthermore, through its venture capital arm, Lockheed Martin Ventures, the company is increasing investments in European defense startups to boost innovation and enhance the region's defense industrial base, according to information shared by Lockheed Martin. These strategic moves are in line with the EU's goals to diminish dependence on non-European defense suppliers, thereby promoting local procurement and advancing Europe’s defense autonomy. Lockheed Martin's involvement with initiatives like the European Defence Industry Programme (EDIP) highlights its commitment to supporting the enhancement of the continent's defense capabilities by engaging in joint procurements and industry investments.